Citigroup Cuts Stevanato Group (NYSE:STVN) Price Target to $26.00

Stevanato Group (NYSE:STVN) had its target price cut by Citigroup from $32.00 to $26.00 in a research note released on Thursday morning,Benzinga reports. They currently have a buy rating on the stock.

A number of other research analysts have also weighed in on the company. KeyCorp decreased their target price on Stevanato Group from $37.00 to $32.00 and set an “overweight” rating on the stock in a report on Thursday. Morgan Stanley initiated coverage on shares of Stevanato Group in a research report on Monday, December 1st. They set an “equal weight” rating and a $24.00 price objective for the company. Jefferies Financial Group set a $17.50 price objective on shares of Stevanato Group in a report on Tuesday, February 10th. Wall Street Zen lowered shares of Stevanato Group from a “buy” rating to a “hold” rating in a research report on Saturday, February 14th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Stevanato Group in a research note on Monday, December 29th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Stevanato Group has an average rating of “Moderate Buy”.

Stevanato Group Stock Performance

STVN opened at €15.46 on Thursday. Stevanato Group has a 12-month low of €13.91 and a 12-month high of €28.00. The stock has a market cap of $4.68 billion, a price-to-earnings ratio of 26.66, a PEG ratio of 1.42 and a beta of 0.57. The business has a 50 day moving average of €17.58 and a 200-day moving average of €21.65. The company has a quick ratio of 1.30, a current ratio of 1.76 and a debt-to-equity ratio of 0.23.

Hedge Funds Weigh In On Stevanato Group

Institutional investors and hedge funds have recently modified their holdings of the business. T. Rowe Price Investment Management Inc. increased its position in Stevanato Group by 10.4% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 3,923,632 shares of the company’s stock worth $78,944,000 after acquiring an additional 368,792 shares during the period. Susquehanna Portfolio Strategies LLC raised its stake in Stevanato Group by 62.8% in the 4th quarter. Susquehanna Portfolio Strategies LLC now owns 72,554 shares of the company’s stock worth $1,460,000 after purchasing an additional 27,991 shares in the last quarter. Millennium Management LLC bought a new stake in Stevanato Group in the 4th quarter valued at about $278,000. Balyasny Asset Management L.P. boosted its holdings in Stevanato Group by 688.3% in the 4th quarter. Balyasny Asset Management L.P. now owns 112,253 shares of the company’s stock valued at $2,259,000 after purchasing an additional 98,013 shares during the period. Finally, Bamco Inc. NY grew its position in shares of Stevanato Group by 1.4% during the 4th quarter. Bamco Inc. NY now owns 2,001,724 shares of the company’s stock worth $40,275,000 after purchasing an additional 27,965 shares in the last quarter.

Key Stories Impacting Stevanato Group

Here are the key news stories impacting Stevanato Group this week:

• Positive Sentiment: Q4 beats and revenue momentum — Stevanato reported Q4 results that beat expectations (reported EPS ~$0.2114 vs. ~$0.20 consensus) and highlighted strong revenue growth, reinforcing demand for its pharmaceutical packaging and high‑value solutions. STVN Q4 Highlights
• Positive Sentiment: 2026 guidance and HVS mix — Management outlined a 2026 revenue target up to €1.308B and expects high‑value solutions (HVS) to reach ~48% of sales, supporting margin expansion potential as capex is mainly HVS‑directed. 2026 Revenue Target Article
• Positive Sentiment: Analyst buy support — At least one note (Seeking Alpha piece) reiterates a Buy thesis citing Q4/FY25 strength and long‑term demand drivers, framing current weakness as cyclical in the Engineering segment. Stevanato: Strong Q4 Results Reinforce Long-Term Growth Story
• Neutral Sentiment: Earnings call detail — Full Q4/FY25 earnings call transcripts and summaries are available for deeper read; they provide management color on capex allocation (heavy toward HVS) and the cyclical pressure in Engineering. Useful for modeling near‑term margin recovery timing. Q4 2025 Earnings Call Summary
• Neutral Sentiment: Transcripts published — Full call transcripts (Seeking Alpha / InsiderMonkey) confirm the beat and provide verbatim management commentary for investors building scenarios. Earnings Call Transcript
• Negative Sentiment: Multiple analyst price‑target cuts — Morgan Stanley cut its PT to $19 and moved to Equal Weight; Citigroup lowered its PT to $26 (maintained Buy); KeyCorp trimmed its PT to $32 (keeps Overweight). Those revisions reduce near‑term upside expectations and likely contributed to selling pressure. Analyst PT Changes (Benzinga) KeyBanc / StreetInsider

Stevanato Group Company Profile

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.